Mightier, provider of a ground-breaking video game system for teaching children emotional regulation, today announced the company has been awarded a $2 million grant from the National Institute of Mental Health (NIMH) to support research on the impact of video games on improving children’s mental health. [Read more…] about Can biofeedback-based videogames help children better manage stress? Magellan Health and Mightier secure $2 million NIMH grant to investigate
Neurolief announced today that it received FDA breakthrough device designation for its Relivion DP system for treating major depression.
Relivion is a wearable, non-invasive, multi-channel brain neuromodulation device designed as an adjunctive treatment to pharmaceutical management of major depressive disorder (MDD) in adults who haven’t experienced satisfactory improvement from antidepressant medications, according to a news release. [Read more…] about Neuromodulation device Relivion gets FDA clearance to help patients with major depression who don’t benefit from antidepressant medications
Scottsdale, Arizona-based Magellan Health announced today that it has launched a pilot of Boston Children’s Hospital spin-out Neuromotion Labs’ Mightier, a biofeedback video game platform designed to help children regulate their emotions.
“Qantas CEO Alan Joyce, who today is in New York for the research flight, told Today Show via a live cross that he will be selecting an aircraft for the mammoth job by the year’s end, in line with a previous time-line.
“The flight is going to be ground-breaking, as you said. We’ve got 19 hours — we’ve got a lot of scientists and we’re looking at different ways of making the operation actually great for our passengers,” Joyce said. [Read more…] about Qantas monitors brainwaves of pilots and passengers to test 19.5‑hour flight from NY to Sydney
It’s time for SharpBrains e‑newsletter discussing the latest research and innovations to help promote brain health, opening in this occasion with a large and worrying study tracking the long-term neural impact of commonly prescribed medications.
New brain research:
- First, do no harm? Common anticholinergic meds seen to increase dementia risk
- …which is one of the many reasons why these 10 highlights from the 2019 SharpBrains Virtual Summit are so important to shape a better system and future
- New study reinforces the importance of walking through forests for mental and general health
- AARP: A majority of Americans believe dietary supplements improve brain health, despite the lack of evidence
New brain technology:
- The Ontario Brain Institute (OBI) announces six new ONtrepreneurs working at the frontier of applied neurotech
- Monitoring the body’s electrical signalling to enhance brain health
- Few wearable neurotechnologies have been directly tested by high-quality, peer-reviewed research
New brain thinking:
- Watch all Recordings from the 2019 SharpBrains Virtual Summit
- July 9th in Toronto, Canada: Latest research findings on Neuroplasticity and Neuropsychology
- Kindle Countdown Deal to read over the summer (and apply!) a great book on brain health and neuro-fitness
- People spent $1.9 billion last year on apps to keep their brains sharp as they age — here’s what actually works
Last but not least, here is a fun brain teaser for the weekend. What do you see?
Have a great month of July,
The SharpBrains Team
“It may look like something befitting Halloween’s Michael Myers, but the device pictured above is actually a breakthrough in neuroscience—a portable, wearable brain scanner that can monitor neural activity while a person is moving [Read more…] about Wearable brain scanners to enable broader, easier, cheaper access to neuroimaging